Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : SARS-CoV-2 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery Platform
Sponsor : CVC Capital Partners
Deal Size : Undisclosed
Deal Type : Collaboration
Ardigen, CVC Collaborate to Develop SARS-CoV-2 Vaccine
Details : Ardigen's neoantigen prediction platform called "ArdImmune Vax" employs state of the art bioinformatics and Artificial Intelligence to identify an optimal set of neoantigens as targets for cancer vaccines or adoptive cell therapies.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
July 13, 2020
Lead Product(s) : SARS-CoV-2 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery Platform
Sponsor : CVC Capital Partners
Deal Size : Undisclosed
Deal Type : Collaboration